Oxytocin parallel dimer

Oxytocin parallel dimer features two oxytocin-like chains arranged in a parallel orientation stabilized by disulfide connectivity. The dimeric arrangement enhances structural rigidity and creates extended interaction surfaces. Researchers use it to examine peptide multimerization, folding cooperativity, and receptor-contact geometry. Its unusual topology supports advanced structural exploration.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Oxytocin parallel dimer(CAS 19645-28-4)

CAT No: R2326

CAS No:19645-28-4

Synonyms/Alias:Oxytocin parallel dimer;19645-28-4;HY-P3215;DA-66427;CS-0169704;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C86H132N24O24S4
M.W/Mr.
2014.4
Sequence
Three Letter Code:H-Cys(1)-Tyr-Ile-Gln-Asn-Cys(2)-Pro-Leu-Gly-NH2.H-Cys(1)-Tyr-Ile-Gln-Asn-Cys(2)-Pro-Leu-Gly-NH2

Oxytocin parallel dimer is a specialized peptide construct comprising two oxytocin molecules covalently linked in a parallel orientation. As a synthetic derivative of the neuropeptide oxytocin, this dimeric form is engineered to explore the impact of peptide multimerization on receptor binding, signaling dynamics, and molecular stability. Its unique structural configuration offers researchers a valuable tool to dissect the biochemical and biophysical consequences of peptide dimerization, providing insights into both fundamental peptide science and the nuanced mechanisms of neuropeptide function. The parallel dimer format is particularly relevant for studies aiming to understand how multivalent peptide architectures influence biological interactions and downstream cellular responses.

Receptor Binding Studies: The parallel dimeric form of oxytocin is frequently employed to investigate the effects of multivalency on oxytocin receptor engagement. By comparing the binding kinetics and affinities of the dimer with those of the monomeric peptide, researchers can elucidate how dimerization alters ligand-receptor interactions. Such studies are instrumental in advancing the understanding of peptide-receptor specificity, allosteric modulation, and potential cooperative binding phenomena that may arise from multimeric ligand presentation.

Peptide Structure-Function Analysis: The dimer serves as a model system for probing the relationship between peptide architecture and biological activity. Utilizing advanced spectroscopic and biophysical techniques, scientists can assess the conformational stability, folding properties, and aggregation tendencies of the parallel dimer in comparison to its monomeric counterpart. These investigations provide critical data on how structural modifications influence peptide behavior, which is essential for rational peptide design and the development of novel biomimetic molecules.

Cell Signaling Research: In cellular assays, the parallel dimeric oxytocin can be used to examine downstream signaling events triggered by multivalent ligand engagement. By evaluating differences in second messenger activation, receptor internalization, or gene expression profiles, researchers gain valuable insights into how dimeric ligands modulate intracellular signaling cascades. This application is particularly relevant for dissecting the molecular mechanisms underlying neuropeptide function in both neuronal and non-neuronal cell models.

Peptide Synthesis and Analytical Method Development: The parallel dimer is also a useful reference standard or test molecule in the optimization of peptide synthesis strategies, purification protocols, and analytical characterization methods. Its defined dimeric structure challenges both synthetic and analytical workflows, making it a relevant benchmark for method validation in high-performance liquid chromatography, mass spectrometry, and related techniques. Such applications support the advancement of peptide chemistry and quality control in research and industry settings.

Biomolecular Interaction Studies: The unique topology of the oxytocin parallel dimer enables detailed investigation of multivalent interactions with proteins, membranes, or other biomolecules. Researchers can utilize the dimer to explore how spatial arrangement and valency affect molecular recognition events, aggregation phenomena, or supramolecular assembly processes. These studies contribute to the broader understanding of multimeric peptide behavior in complex biological environments, informing the design of next-generation peptide-based probes and materials.

InChI
InChI=1S/C86H132N24O24S4/c1-9-43(7)69-83(131)97-51(23-25-63(89)113)75(123)101-57(33-65(91)115)77(125)105-59(85(133)109-27-11-13-61(109)81(129)103-53(29-41(3)4)73(121)95-35-67(93)117)39-137-138-40-60(86(134)110-28-12-14-62(110)82(130)104-54(30-42(5)6)74(122)96-36-68(94)118)106-78(126)58(34-66(92)116)102-76(124)52(24-26-64(90)114)98-84(132)70(44(8)10-2)108-80(128)56(32-46-17-21-48(112)22-18-46)100-72(120)50(88)38-136-135-37-49(87)71(119)99-55(79(127)107-69)31-45-15-19-47(111)20-16-45/h15-22,41-44,49-62,69-70,111-112H,9-14,23-40,87-88H2,1-8H3,(H2,89,113)(H2,90,114)(H2,91,115)(H2,92,116)(H2,93,117)(H2,94,118)(H,95,121)(H,96,122)(H,97,131)(H,98,132)(H,99,119)(H,100,120)(H,101,123)(H,102,124)(H,103,129)(H,104,130)(H,105,125)(H,106,126)(H,107,127)(H,108,128)/t43-,44-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,69-,70-/m0/s1
InChI Key
QJTGOPRBCPCYLF-AQFNFDSMSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesPeptide Nucleic Acids SynthesisPeptide Analysis ServicesPeptide Synthesis ServicesPeptide CDMOEpitope Mapping ServicescGMP Peptide ServiceCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers